JAK1/JAK2 inhibitor baricitinib ameliorates sepsis-induced acute kidney injury in rats
- 27 May 2025
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1002, 177770
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Models of sepsis-induced acute kidney injuryLife Sciences, 2024
- Baricitinib relieves DSS-induced ulcerative colitis in mice by suppressing the NF-κB and JAK2/STAT3 signalling pathwaysInflammopharmacology, 2024
- Pectolinarigenin alleviated septic acute kidney injury via inhibiting Jak2/Stat3 signaling and mitochondria dysfunctionBiomedicine & Pharmacotherapy, 2023
- Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia–reperfusion injury via toll-like receptor 4/nuclear factor-kappa B pathwayInternational Immunopharmacology, 2022
- The ameliorating effect of cannabinoid type 2 receptor activation on brain, lung, liver and heart damage in cecal ligation and puncture-induced sepsis model in ratsInternational Immunopharmacology, 2020
- Upregulation of NLRP3 via STAT3-dependent histone acetylation contributes to painful neuropathy induced by bortezomibExperimental Neurology, 2018
- Sepsis and septic shock: New definitions, new diagnostic and therapeutic approachesJournal of Global Antimicrobial Resistance, 2017
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI studyIntensive Care Medicine, 2015
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in TumorsCancer Cell, 2009